multi-omics resolves a sharp disease-state shift between mild and moderate covid-19 | yapeng su
Published 3 years ago • 317 plays • Length 22:16Download video MP4
Download video MP3
Similar videos
-
57:42
behind the scenes of a covid-19 lab
-
31:37
crispr, genetic disease, and covid-19
-
24:10
sars-cov-2 and the covid-19 pandemic
-
1:00:40
multi-omics in health and disease (session 2)
-
18:23
dissecting immune mechanisms of chronic disease with single cell genomic technologies
-
4:26
multiomics is changing the game - hear from researchers using it
-
3:26
multiomics: fueling breakthroughs in cancer research
-
10:20
engineering viruses - leor weinberger - gladstone institutes 2016 fall symposium
-
59:46
omicron update—january 31, 2022
-
44:17
multi-omics in health and disease (welcome and workshop rationale)
-
31:41
revealing rare cell types through single cell multiomics: a covid 19 study
-
21:55
finding our way out: how science can overcome the covid-19 crisis
-
25:42
covid-19 research using ips cells and organoids | kazuo takayama, phd
-
1:18:40
the future of precision medicine - gladstone institutes 2016 spring symposium
-
55:09
understanding the 2019 novel coronavirus outbreak
-
28:26
[joana p. bernardes & neha mishra] longitudinal multi-omics identify hallmarks of severe covid-19
-
12:54
covid-19 variants with melanie ott—february 4, 2021
-
54:39
using single cell multi-omics to analyse the immune system
-
59:48
maximizing philanthropic impact in the fight against covid-19
-
1:12:19
session 1 - covid-19 genomics and variant analysis
-
1:01:57
single-cell multi-omics for immuno-oncology
-
56:55
integration of single cell spatial technologies enables granular characterization of covid-19